Congo, Democratic Republic of the vs Congo: HIV positive pregnant women receiving antiretrovirals, using

Congo, Democratic Republic of the
11.0%
in 2009
Congo
7.0%
in 2011
Congo, Democratic Republic of the rank
35th
Congo rank
36th

HIV positive pregnant women receiving antiretrovirals, using over time

  • Congo, Democratic Republic of the
  • Congo
51015202530200420072011

How they compare

Congo, Democratic Republic of the currently reports 11.0% against 7.0% in Congo, a difference of 4.0%.

That makes Congo, Democratic Republic of the's figure about 1.6 times Congo's.

The two have swapped places 2 times across 5 shared years of data; in 2004 it was Congo ahead.

Congo, Democratic Republic of the ranks 35th and Congo ranks 36th of 38 countries.

Congo has averaged higher in every one of the 1 decades both report.

Frequently asked questions

Which has higher hiv positive pregnant women receiving antiretrovirals, using, Congo, Democratic Republic of the or Congo?
Congo, Democratic Republic of the, at 11.0% against 7.0% in Congo as of 2009.
What is the difference in hiv positive pregnant women receiving antiretrovirals, using between Congo, Democratic Republic of the and Congo?
4.0%, with Congo, Democratic Republic of the ahead.
How many years of comparable data are there for Congo, Democratic Republic of the and Congo?
5 years are reported by both, from 2004 to 2009.
How do Congo, Democratic Republic of the and Congo rank globally for hiv positive pregnant women receiving antiretrovirals, using?
Congo, Democratic Republic of the ranks 35th and Congo ranks 36th of 38 countries.
Where does this data come from?
http://data.unaids.org/pub/GlobalReport/2008/, published as HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Congo, Democratic Republic of the vs Congo: HIV positive pregnant women receiving antiretrovirals, using. Statizoid, drawing on http://data.unaids.org/pub/GlobalReport/2008/. Retrieved 12 September 2026, from https://health.statizoid.com/compare/hiv-positive-pregnant-women-receiving-antiretrovirals-using-who-unaids-methodology/congo-dem-rep/congo-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/hiv-positive-pregnant-women-receiving-antiretrovirals-using-who-unaids-methodology/congo-dem-rep/congo-rep/">Congo, Democratic Republic of the vs Congo: HIV positive pregnant women receiving antiretrovirals, using</a> — Statizoid

About this data

Indicator
HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate)
Unit
%; high estimate
Source
http://data.unaids.org/pub/GlobalReport/2008/
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
38 places, 216 data points, 2004–2011
Last refreshed

Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.